Molecular mechanisms of retroviral integration site selection

Nucleic Acids Research

Volumn 42, Issue 16, 2014, Pages 10209-10225

  Kvaratskhelia, Mamuka ^a   Sharma, Amit ^a   Larue, Ross C ^a   Serrao, Erik ^b   Engelman, Alan ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; PROTEIN BET; PROTEIN P75; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; LENS EPITHELIUM-DERIVED GROWTH FACTOR; SIGNAL PEPTIDE;

ENHANCER REGION; EPIGENETICS; GENE INSERTION; GENE INSERTION SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ANALYSIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; CHEMISTRY; ENZYMOLOGY; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; MOLONEY MURINE LEUKEMIA VIRUS; PHYSIOLOGY;

GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS;

GENETIC THERAPY; GENETIC VECTORS; HIV-1; HUMANS; INTEGRASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLONEY MURINE LEUKEMIA VIRUS; VIRUS INTEGRATION;

EID: 84921369549     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku769     Document Type: Review

References (186)

1. Bushman, F.D. Bushman, F.D. (2007) Retroviral integration and human gene therapy. J. Clin. Invest., 117, 2083-2086.
2. Engelman, A.Engelman, A. (1994) Most of the avian genome appears available for retroviral DNA integration. Bioessays, 16, 797-799.
3. Carteau, S., Hoffmann, C., and Bushman, F.Carteau, S., Hoffmann, C., and Bushman, F. (1998) Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol., 72, 4005-4014.
4. Derse, D., Crise, B., Li, Y., Princler, G., Lum, N., Stewart, C., McGrath, C.F., Hughes, S.H., Munroe, D.J., and Wu, X.Derse, D., Crise, B., Li, Y., Princler, G., Lum, N., Stewart, C., McGrath, C.F., Hughes, S.H., Munroe, D.J., and Wu, X. (2007) Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J. Virol., 81, 6731-6741.
5. Cavazza, A., Moiani, A., and Mavilio, F.Cavazza, A., Moiani, A., and Mavilio, F. (2013) Mechanisms of retroviral integration and mutagenesis. Hum. Gene Ther., 24, 119-131.
6. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R., and Bushman, F.Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R., and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
7. Wu, X., Li, Y., Crise, B., and Burgess, S.M.Wu, X., Li, Y., Crise, B., and Burgess, S.M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749-1751.
8. LaFave, M.C., Varshney, G.K., Gildea, D.E., Wolfsberg, T.G., Baxevanis, A.D., and Burgess, S.M.LaFave, M.C., Varshney, G.K., Gildea, D.E., Wolfsberg, T.G., Baxevanis, A.D., and Burgess, S.M. (2014) MLV integration site selection is driven by strong enhancers and active promoters. Nucleic Acids Res., 42, 4257-4269.
9. De Ravin, S.S., Su, L., Theobald, N., Choi, U., Macpherson, J.L., Poidinger, M., Symonds, G., Pond, S.M., Ferris, A.L., and Hughes, S.H. et al. De Ravin, S.S., Su, L., Theobald, N., Choi, U., Macpherson, J.L., Poidinger, M., Symonds, G., Pond, S.M., Ferris, A.L., and Hughes, S.H. (2014) Enhancers are major targets for murine leukemia virus vector integration. J. Virol., 88, 4504-4513.
10. Narezkina, A., Taganov, K.D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A.M., and Katz, R.A. Narezkina, A., Taganov, K.D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A.M., and Katz, R.A. (2004) Genome-wide analyses of avian sarcoma virus integration sites. J. Virol., 78, 11656-11663.
11. Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Gunzburg, W.H., and Indik, S.Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Gunzburg, W.H., and Indik, S. (2008) Mouse mammary tumor virus integration site selection in human and mouse genomes. J. Virol., 82, 1360-1367.
12. Konstantoulas, C.J. and Indik, S.Konstantoulas, C.J. and Indik, S. (2014) Mouse mammary tumor virus-based vector transduces non-dividing cells, enters the nucleus via a TNPO3-independent pathway and integrates in a less biased fashion than other retroviruses. Retrovirology, 11, 34.
13. Lewinski, M.K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., and Hannenhalli, S. et al. Lewinski, M.K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., and Hannenhalli, S. (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog., 2, e60.
14. Ciuffi, A. and Bushman, F.D.Ciuffi, A. and Bushman, F.D. (2006) Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet., 22, 388-395.
15. Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J.R., and Bushman, F.Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J.R., and Bushman, F. (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med., 11, 1287-1289.
16. Marshall, H.M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., and Bushman, F.D.Marshall, H.M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., and Bushman, F.D. (2007) Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One, 2, e1340.
17. Shun, M.C., Raghavendra, N.K., Vandegraaff, N., Daigle, J.E., Hughes, S., Kellam, P., Cherepanov, P., and Engelman, A.Shun, M.C., Raghavendra, N.K., Vandegraaff, N., Daigle, J.E., Hughes, S., Kellam, P., Cherepanov, P., and Engelman, A. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev., 21, 1767-1778.
18. Schrijvers, R., De Rijck, J., Demeulemeester, J., Adachi, N., Vets, S., Ronen, K., Christ, F., Bushman, F.D., Debyser, Z., and Gijsbers, R.Schrijvers, R., De Rijck, J., Demeulemeester, J., Adachi, N., Vets, S., Ronen, K., Christ, F., Bushman, F.D., Debyser, Z., and Gijsbers, R. (2012) LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs. PLoS Pathog., 8, e1002558.
19. Sharma, A., Larue, R.C., Plumb, M.R., Malani, N., Male, F., Slaughter, A., Kessl, J.J., Shkriabai, N., Coward, E., and Aiyer, S.S. et al. Sharma, A., Larue, R.C., Plumb, M.R., Malani, N., Male, F., Slaughter, A., Kessl, J.J., Shkriabai, N., Coward, E., and Aiyer, S.S. (2013) BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc. Natl. Acad. Sci. U.S.A., 110, 12036-12041.
20. Gupta, S.S., Maetzig, T., Maertens, G.N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., and Schulz, T.F.Gupta, S.S., Maetzig, T., Maertens, G.N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., and Schulz, T.F. (2013) Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J. Virol., 87, 12721-12736.
21. De Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F.D., Landuyt, B., Husson, S.J., and Busschots, K. et al. De Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F.D., Landuyt, B., Husson, S.J., and Busschots, K. (2013) The BET family of proteins targets Moloney murine leukemia virus integration near transcription start sites. Cell Rep., 5, 886-894.
22. Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J.K.Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J.K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A., 90, 8033-8037.
23. Kafri, T.Kafri, T. (2004) Gene delivery by lentivirus vectors an overview. Methods Mol. Biol., 246, 367-390.
24. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., and Casanova, J.L. et al. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., and Casanova, J.L. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669-672.
25. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., and Cavazzana-Calvo, M. et al. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., and Cavazzana-Calvo, M. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.N. Engl. J. Med., 348, 255-256.
26. Schmidt, M., Zickler, P., Hoffmann, G., Haas, S., Wissler, M., Muessig, A., Tisdale, J.F., Kuramoto, K., Andrews, R.G., and Wu, T. et al. Schmidt, M., Zickler, P., Hoffmann, G., Haas, S., Wissler, M., Muessig, A., Tisdale, J.F., Kuramoto, K., Andrews, R.G., and Wu, T. (2002) Polyclonal long-term repopulating stem cell clones in a primate model. Blood, 100, 2737-2743.
27. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., and Morillon, E. et al. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., and Morillon, E. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415-419.
28. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., and Beldjord, K. et al. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., and Beldjord, K. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 118, 3132-3142.
29. Bushman, F.D., Fujiwara, T., and Craigie, R.Bushman, F.D., Fujiwara, T., and Craigie, R. (1990) Retroviral DNA integration directed by HIV integration protein in vitro. Science, 249, 1555-1558.
30. Engelman, A., Mizuuchi, K., and Craigie, R.Engelman, A., Mizuuchi, K., and Craigie, R. (1991) HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell, 67, 1211-1221.
31. Maertens, G.N., Hare, S., and Cherepanov, P.Maertens, G.N., Hare, S., and Cherepanov, P. (2010) The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature, 468, 326-329.
32. Hare, S., Maertens, G.N., and Cherepanov, P.Hare, S., Maertens, G.N., and Cherepanov, P. (2012) 3′-processing and strand transfer catalysed by retroviral integrase in crystallo. EMBO J., 31, 3020-3028.
33. Pryciak, P.M., Sil, A., and Varmus, H.E.Pryciak, P.M., Sil, A., and Varmus, H.E. (1992) Retroviral integration into minichromosomes in vitro. EMBO J., 11, 291-303.
34. Pryciak, P.M. and Varmus, H.E.Pryciak, P.M. and Varmus, H.E. (1992) Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell, 69, 769-780.
35. Pruss, D., Reeves, R., Bushman, F.D., and Wolffe, A.P.Pruss, D., Reeves, R., Bushman, F.D., and Wolffe, A.P. (1994) The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem., 269, 25031-25041.
36. Pruss, D., Bushman, F.D., and Wolffe, A.P.Pruss, D., Bushman, F.D., and Wolffe, A.P. (1994) Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. U.S.A., 91, 5913-5917.
37. Katz, R.A., Gravuer, K., and Skalka, A.M.Katz, R.A., Gravuer, K., and Skalka, A.M. (1998) A preferred target DNA structure for retroviral integrase in vitro. J. Biol. Chem., 273, 24190-24195.
38. Stevens, S.W. and Griffith, J.D.Stevens, S.W. and Griffith, J.D. (1996) Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J. Virol., 70, 6459-6462.
39. Holman, A.G. and Coffin, J.M.Holman, A.G. and Coffin, J.M. (2005) Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. U.S.A., 102, 6103-6107.
40. Wu, X., Li, Y., Crise, B., Burgess, S.M., and Munroe, D.J.Wu, X., Li, Y., Crise, B., Burgess, S.M., and Munroe, D.J. (2005) Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J. Virol., 79, 5211-5214.
41. Berry, C., Hannenhalli, S., Leipzig, J., and Bushman, F.D.Berry, C., Hannenhalli, S., Leipzig, J., and Bushman, F.D. (2006) Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol., 2, e157.
42. Valkov, E., Gupta, S.S., Hare, S., Helander, A., Roversi, P., McClure, M., and Cherepanov, P.Valkov, E., Gupta, S.S., Hare, S., Helander, A., Roversi, P., McClure, M., and Cherepanov, P. (2009) Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res., 37, 243-255.
43. Johnson, R.C., Stella, S., and Heiss, J.K. Rice, PA and Correll, CCEds.Johnson, R.C., Stella, S., and Heiss, J.K.In:edspp.Johnson, R.C., Stella, S., and Heiss, J.K. (2008) In: Protein-Nucleic Acid Interactions: Structural Biology, Rice, PA and Correll, CCEds. RSC Publishing, London. pp. 176-220.
44. Li, X., Krishnan, L., Cherepanov, P., and Engelman, A.Li, X., Krishnan, L., Cherepanov, P., and Engelman, A. (2011) Structural biology of retroviral DNA integration. Virology, 411, 194-205.
45. Serrao, E., Krishnan, L., Shun, M.C., Li, X., Cherepanov, P., Engelman, A., and Maertens, G.N.Serrao, E., Krishnan, L., Shun, M.C., Li, X., Cherepanov, P., Engelman, A., and Maertens, G.N. (2014) Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding. Nucleic Acids Res., 42, 5164-5176.
46. Devroe, E. and Silver, P.A.Devroe, E. and Silver, P.A. (2002) Retrovirus-delivered siRNA. BMC Biotechnol., 2, 15.
47. Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z.Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z. (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem., 278, 372-381.
48. Turlure, F., Devroe, E., Silver, P.A., and Engelman, A.Turlure, F., Devroe, E., Silver, P.A., and Engelman, A. (2004) Human cell proteins and human immunodeficiency virus DNA integration. Front. Biosci., 9, 3187-3208.
49. Emiliani, S., Mousnier, A., Busschots, K., Maroun, M., Van Maele, B., Tempe, D., Vandekerckhove, L., Moisant, F., Ben-Slama, L., and Witvrouw, M. et al. Emiliani, S., Mousnier, A., Busschots, K., Maroun, M., Van Maele, B., Tempe, D., Vandekerckhove, L., Moisant, F., Ben-Slama, L., and Witvrouw, M. (2005) Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem., 280, 25517-25523.
50. Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y.Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y. (2003) LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem., 278, 33528-33539.
51. Llano, M., Delgado, S., Vanegas, M., and Poeschla, E.M.Llano, M., Delgado, S., Vanegas, M., and Poeschla, E.M. (2004) Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem., 279, 55570-55577.
52. Ge, H., Si, Y., and Roeder, R.G.Ge, H., Si, Y., and Roeder, R.G. (1998) Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J., 17, 6723-6729.
53. Hendrix, J., Gijsbers, R., De Rijck, J., Voet, A., Hotta, J., McNeely, M., Hofkens, J., Debyser, Z., and Engelborghs, Y.Hendrix, J., Gijsbers, R., De Rijck, J., Voet, A., Hotta, J., McNeely, M., Hofkens, J., Debyser, Z., and Engelborghs, Y. (2011) The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering. Nucleic Acids Res., 39, 1310-1325.
54. Maertens, G.N., Cherepanov, P., and Engelman, A.Maertens, G.N., Cherepanov, P., and Engelman, A. (2006) Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J. Cell Sci., 119, 2563-2571.
55. Bartholomeeusen, K., De Rijck, J., Busschots, K., Desender, L., Gijsbers, R., Emiliani, S., Benarous, R., Debyser, Z., and Christ, F.Bartholomeeusen, K., De Rijck, J., Busschots, K., Desender, L., Gijsbers, R., Emiliani, S., Benarous, R., Debyser, Z., and Christ, F. (2007) Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J. Mol. Biol., 372, 407-421.
56. Hughes, S., Jenkins, V., Dar, M.J., Engelman, A., and Cherepanov, P.Hughes, S., Jenkins, V., Dar, M.J., Engelman, A., and Cherepanov, P. (2010) Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity. J. Biol. Chem., 285, 541-554.
57. Bartholomeeusen, K., Christ, F., Hendrix, J., Rain, J.C., Emiliani, S., Benarous, R., Debyser, Z., Gijsbers, R., and De Rijck, J.Bartholomeeusen, K., Christ, F., Hendrix, J., Rain, J.C., Emiliani, S., Benarous, R., Debyser, Z., Gijsbers, R., and De Rijck, J. (2009) Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ. J. Biol. Chem., 284, 11467-11477.
58. Yokoyama, A. and Cleary, M.L.Yokoyama, A. and Cleary, M.L. (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell, 14, 36-46.
59. Llano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., and Poeschla, E.M.Llano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., and Poeschla, E.M. (2006) Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J. Mol. Biol., 360, 760-773.
60. Turlure, F., Maertens, G., Rahman, S., Cherepanov, P., and Engelman, A.Turlure, F., Maertens, G., Rahman, S., Cherepanov, P., and Engelman, A. (2006) A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res., 34, 1653-1675.
61. Cherepanov, P., Devroe, E., Silver, P.A., and Engelman, A.Cherepanov, P., Devroe, E., Silver, P.A., and Engelman, A. (2004) Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J. Biol. Chem., 279, 48883-48892.
62. Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., and Poeschla, E.M.Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., and Poeschla, E.M. (2004) LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol., 78, 9524-9537.
63. Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., and Debyser, Z.Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., and Debyser, Z. (2005) The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem., 280, 17841-17847.
64. Cherepanov, P.Cherepanov, P. (2007) LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res., 35, 113-124.
65. Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., and Debyser, Z.Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., and Debyser, Z. (2006) Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol., 80, 1886-1896.
66. Zielske, S.P. and Stevenson, M.Zielske, S.P. and Stevenson, M. (2006) Modest but Reproducible Inhibition of Human Immunodeficiency Virus Type 1 Infection in Macrophages following LEDGFp75 Silencing. J. Virol., 80, 7275-7280.
67. Llano, M., Saenz, D.T., Meehan, A., Wongthida, P., Peretz, M., Walker, W.H., Teo, W., and Poeschla, E.M.Llano, M., Saenz, D.T., Meehan, A., Wongthida, P., Peretz, M., Walker, W.H., Teo, W., and Poeschla, E.M. (2006) An essential role for LEDGF/p75 in HIV integration. Science, 314, 461-464.
68. Fadel, H.J., Morrison, J.H., Saenz, D.T., Fuchs, J.R., Kvaratskhelia, M., Ekker, S.C., and Poeschla, E.M.Fadel, H.J., Morrison, J.H., Saenz, D.T., Fuchs, J.R., Kvaratskhelia, M., Ekker, S.C., and Poeschla, E.M. (2014) TALEN knockout of the PSIP1 gene in human cells: Analyses of HIV-1 replication and allosteric integrase inhibitor mechanism. J. Virol., 88, 9704-9717.
69. De Rijck, J., Vandekerckhove, L., Gijsbers, R., Hombrouck, A., Hendrix, J., Vercammen, J., Engelborghs, Y., Christ, F., and Debyser, Z.De Rijck, J., Vandekerckhove, L., Gijsbers, R., Hombrouck, A., Hendrix, J., Vercammen, J., Engelborghs, Y., Christ, F., and Debyser, Z. (2006) Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J. Virol., 80, 11498-11509.
70. Meehan, A.M., Saenz, D.T., Morrison, J., Hu, C., Peretz, M., and Poeschla, E.M.Meehan, A.M., Saenz, D.T., Morrison, J., Hu, C., Peretz, M., and Poeschla, E.M. (2011) LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity. J. Virol., 85, 3570-3583.
71. Meehan, A.M., Saenz, D.T., Morrison, J.H., Garcia-Rivera, J.A., Peretz, M., Llano, M., and Poeschla, E.M.Meehan, A.M., Saenz, D.T., Morrison, J.H., Garcia-Rivera, J.A., Peretz, M., Llano, M., and Poeschla, E.M. (2009) LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog., 5, e1000522.
72. Ferris, A.L., Wu, X., Hughes, C.M., Stewart, C., Smith, S.J., Milne, T.A., Wang, G.G., Shun, M.C., Allis, C.D., and Engelman, A. et al. Ferris, A.L., Wu, X., Hughes, C.M., Stewart, C., Smith, S.J., Milne, T.A., Wang, G.G., Shun, M.C., Allis, C.D., and Engelman, A. (2010) Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc. Natl. Acad. Sci. U.S.A., 107, 3135-3140.
73. Gijsbers, R., Ronen, K., Vets, S., Malani, N., De Rijck, J., McNeely, M., Bushman, F.D., and Debyser, Z.Gijsbers, R., Ronen, K., Vets, S., Malani, N., De Rijck, J., McNeely, M., Bushman, F.D., and Debyser, Z. (2010) LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol. Ther., 18, 552-560.
74. Silvers, R.M., Smith, J.A., Schowalter, M., Litwin, S., Liang, Z., Geary, K., and Daniel, R.Silvers, R.M., Smith, J.A., Schowalter, M., Litwin, S., Liang, Z., Geary, K., and Daniel, R. (2010) Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein. Hum. Gene Ther., 21, 337-349.
75. De Rijck, J., Bartholomeeusen, K., Ceulemans, H., Debyser, Z., and Gijsbers, R.De Rijck, J., Bartholomeeusen, K., Ceulemans, H., Debyser, Z., and Gijsbers, R. (2010) High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region. Nucleic Acids Res., 38, 6135-6147.
76. Pandey, K.K., Sinha, S., and Grandgenett, D.P.Pandey, K.K., Sinha, S., and Grandgenett, D.P. (2007) Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration. J. Virol., 81, 3969-3979.
77. McKee, C.J., Kessl, J.J., Shkriabai, N., Dar, M.J., Engelman, A., and Kvaratskhelia, M.McKee, C.J., Kessl, J.J., Shkriabai, N., Dar, M.J., Engelman, A., and Kvaratskhelia, M. (2008) Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J. Biol. Chem., 283, 31802-31812.
78. Vanegas, M., Llano, M., Delgado, S., Thompson, D., Peretz, M., and Poeschla, E.Vanegas, M., Llano, M., Delgado, S., Thompson, D., Peretz, M., and Poeschla, E. (2005) Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci., 118, 1733-1743.
79. Vandegraaff, N., Devroe, E., Turlure, F., Silver, P.A., and Engelman, A.Vandegraaff, N., Devroe, E., Turlure, F., Silver, P.A., and Engelman, A. (2006) Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology, 346, 415-426.
80. Wang, H., Jurado, K.A., Wu, X., Shun, M.C., Li, X., Ferris, A.L., Smith, S.J., Patel, P.A., Fuchs, J.R., and Cherepanov, P. et al. Wang, H., Jurado, K.A., Wu, X., Shun, M.C., Li, X., Ferris, A.L., Smith, S.J., Patel, P.A., Fuchs, J.R., and Cherepanov, P. (2012) HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor. Nucleic Acids Res., 40, 11518-11530.
81. Schrijvers, R., Vets, S., De Rijck, J., Malani, N., Bushman, F.D., Debyser, Z., and Gijsbers, R.Schrijvers, R., Vets, S., De Rijck, J., Malani, N., Bushman, F.D., Debyser, Z., and Gijsbers, R. (2012) HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells. Retrovirology, 9, 84.
82. Studamire, B. and Goff, S.P.Studamire, B. and Goff, S.P. (2008) Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology, 5, 48.
83. Wu, S.Y. and Chiang, C.M.Wu, S.Y. and Chiang, C.M. (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem., 282, 13141-13145.
84. Belkina, A.C. and Denis, G.V.Belkina, A.C. and Denis, G.V. (2012) BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer, 12, 465-477.
85. Moriniere, J., Rousseaux, S., Steuerwald, U., Soler-Lopez, M., Curtet, S., Vitte, A.L., Govin, J., Gaucher, J., Sadoul, K., and Hart, D.J. et al. Moriniere, J., Rousseaux, S., Steuerwald, U., Soler-Lopez, M., Curtet, S., Vitte, A.L., Govin, J., Gaucher, J., Sadoul, K., and Hart, D.J. (2009) Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature, 461, 664-668.
86. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., and Felletar, I. et al. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., and Felletar, I. (2010) Selective inhibition of BET bromodomains. Nature, 468, 1067-1073.
87. Larue, R.C., Plumb, M.R., Crowe, B.L., Shkriabai, N., Sharma, A., Difiore, J., Malani, N., Aiyer, S.S., Roth, M.J., and Bushman, F.D. et al. Larue, R.C., Plumb, M.R., Crowe, B.L., Shkriabai, N., Sharma, A., Difiore, J., Malani, N., Aiyer, S.S., Roth, M.J., and Bushman, F.D. (2014) Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes. Nucleic Acids Res., 42, 4868-4881.
88. Wu, S.Y., Lee, A.Y., Lai, H.T., Zhang, H., and Chiang, C.M.Wu, S.Y., Lee, A.Y., Lai, H.T., Zhang, H., and Chiang, C.M. (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol. Cell, 49, 843-857.
89. Bisgrove, D.A., Mahmoudi, T., Henklein, P., and Verdin, E.Bisgrove, D.A., Mahmoudi, T., Henklein, P., and Verdin, E. (2007) Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc. Natl. Acad. Sci. U.S.A., 104, 13690-13695.
90. Zhu, J., Gaiha, G.D., John, S.P., Pertel, T., Chin, C.R., Gao, G., Qu, H., Walker, B.D., Elledge, S.J., and Brass, A.L.Zhu, J., Gaiha, G.D., John, S.P., Pertel, T., Chin, C.R., Gao, G., Qu, H., Walker, B.D., Elledge, S.J., and Brass, A.L. (2012) Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep., 2, 807-816.
91. Boehm, D., Calvanese, V., Dar, R.D., Xing, S., Schroeder, S., Martins, L., Aull, K., Li, P.C., Planelles, V., and Bradner, J.E. et al. Boehm, D., Calvanese, V., Dar, R.D., Xing, S., Schroeder, S., Martins, L., Aull, K., Li, P.C., Planelles, V., and Bradner, J.E. (2012) BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle, 12, 452-462.
92. Weidner-Glunde, M., Ottinger, M., and Schulz, T.F.Weidner-Glunde, M., Ottinger, M., and Schulz, T.F. (2010) WHAT do viruses BET on. Front. Biosci., 15, 537-549.
93. You, J., Croyle, J.L., Nishimura, A., Ozato, K., and Howley, P.M.You, J., Croyle, J.L., Nishimura, A., Ozato, K., and Howley, P.M. (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell, 117, 349-360.
94. Baxter, M.K., McPhillips, M.G., Ozato, K., and McBride, A.A.Baxter, M.K., McPhillips, M.G., Ozato, K., and McBride, A.A. (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol., 79, 4806-4818.
95. Banerjee, C., Archin, N., Michaels, D., Belkina, A.C., Denis, G.V., Bradner, J., Sebastiani, P., Margolis, D.M., and Montano, M.Banerjee, C., Archin, N., Michaels, D., Belkina, A.C., Denis, G.V., Bradner, J., Sebastiani, P., Margolis, D.M., and Montano, M. (2012) BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J. Leukoc. Biol., 92, 1147-1154.
96. Li, Z., Guo, J., Wu, Y., and Zhou, Q.Li, Z., Guo, J., Wu, Y., and Zhou, Q. (2013) The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res., 41, 277-287.
97. Wu, S.Y., Lee, A.Y., Hou, S.Y., Kemper, J.K., Erdjument-Bromage, H., Tempst, P., and Chiang, C.M.Wu, S.Y., Lee, A.Y., Hou, S.Y., Kemper, J.K., Erdjument-Bromage, H., Tempst, P., and Chiang, C.M. (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev., 20, 2383-2396.
98. Olejnik-Schmidt, A.K., Schmidt, M.T., Kedzia, W., and Gozdzicka-Jozefiak, A.Olejnik-Schmidt, A.K., Schmidt, M.T., Kedzia, W., and Gozdzicka-Jozefiak, A. (2008) Search for cellular partners of human papillomavirus type 16 E2 protein. Arch. Virol., 153, 983-990.
99. Chiang, C.M.Chiang, C.M. (2009) Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biol. Rep., 1, 98.
100. Leroy, G., Chepelev, I., Dimaggio, P.A., Blanco, M.A., Zee, B.M., Zhao, K., and Garcia, B.A. Leroy, G., Chepelev, I., Dimaggio, P.A., Blanco, M.A., Zee, B.M., Zhao, K., and Garcia, B.A. (2012) Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome Biol., 13, R68.
101. Nicodeme, E., Jeffrey, K.L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.W., Chandwani, R., Marazzi, I., Wilson, P., and Coste, H. et al. Nicodeme, E., Jeffrey, K.L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.W., Chandwani, R., Marazzi, I., Wilson, P., and Coste, H. (2010) Suppression of inflammation by a synthetic histone mimic. Nature, 468, 1119-1123.
102. Zheng, R., Jenkins, T.M., and Craigie, R.Zheng, R., Jenkins, T.M., and Craigie, R. (1996) Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. U.S.A., 93, 13659-13664.
103. Hare, S., Gupta, S.S., Valkov, E., Engelman, A., and Cherepanov, P.Hare, S., Gupta, S.S., Valkov, E., Engelman, A., and Cherepanov, P. (2010) Retroviral intasome assembly and inhibition of DNA strand transfer. Nature, 464, 232-236.
104. Krishnan, L., Li, X., Naraharisetty, H.L., Hare, S., Cherepanov, P., and Engelman, A.Krishnan, L., Li, X., Naraharisetty, H.L., Hare, S., Cherepanov, P., and Engelman, A. (2010) Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc. Natl. Acad. Sci. U.S.A., 107, 15910-15915.
105. Kessl, J.J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J.O., Feng, L., Musier-Forsyth, K., Craigie, R., and Kvaratskhelia, M.Kessl, J.J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J.O., Feng, L., Musier-Forsyth, K., Craigie, R., and Kvaratskhelia, M. (2011) FRET analysis reveals distinct conformations of IN tetramers in the presence of viral DNA or LEDGF/p75. Nucleic Acids Res., 39, 9009-9022.
106. Johnson, B.C., Metifiot, M., Ferris, A., Pommier, Y., and Hughes, S.H.Johnson, B.C., Metifiot, M., Ferris, A., Pommier, Y., and Hughes, S.H. (2013) A homology model of HIV-1 integrase and analysis of mutations designed to test the model. J. Mol. Biol., 425, 2133-2146.
107. DeAnda, F., Hightower, K.E., Nolte, R.T., Hattori, K., Yoshinaga, T., Kawasuji, T., and Underwood, M.R.DeAnda, F., Hightower, K.E., Nolte, R.T., Hattori, K., Yoshinaga, T., Kawasuji, T., and Underwood, M.R. (2013) Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics. PLoS One, 8, e77448.
108. Cherepanov, P., Ambrosio, A.L., Rahman, S., Ellenberger, T., and Engelman, A.Cherepanov, P., Ambrosio, A.L., Rahman, S., Ellenberger, T., and Engelman, A. (2005) Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. U.S.A., 102, 17308-17313.
109. Hare, S., Shun, M.C., Gupta, S.S., Valkov, E., Engelman, A., and Cherepanov, P.Hare, S., Shun, M.C., Gupta, S.S., Valkov, E., Engelman, A., and Cherepanov, P. (2009) A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75. PLoS Pathog., 5, e1000259.
110. Cherepanov, P., Sun, Z.Y., Rahman, S., Maertens, G., Wagner, G., and Engelman, A.Cherepanov, P., Sun, Z.Y., Rahman, S., Maertens, G., Wagner, G., and Engelman, A. (2005) Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat. Struct. Mol. Biol., 12, 526-532.
111. Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., and Cherepanov, P.Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., and Cherepanov, P. (2009) Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog., 5, e1000515.
112. Aiyer, S., Swapna, G.V.T., Malani, N., Aramini, J.M., Schneider, W.M., Plumb, M.R., Ghanem, M., Larue, R.C., Sharma, A., and Studamire, B. et al. Aiyer, S., Swapna, G.V.T., Malani, N., Aramini, J.M., Schneider, W.M., Plumb, M.R., Ghanem, M., Larue, R.C., Sharma, A., and Studamire, B. (2014) Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. Nucleic Acids Res., 42, 5917-5928.
113. Roth, M.J.Roth, M.J. (1991) Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J. Virol., 65, 2141-2145.
114. Xie, W., Gai, X., Zhu, Y., Zappulla, D.C., Sternglanz, R., and Voytas, D.F.Xie, W., Gai, X., Zhu, Y., Zappulla, D.C., Sternglanz, R., and Voytas, D.F. (2001) Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol. Cell. Biol., 21, 6606-6614.
115. Zhu, Y., Dai, J., Fuerst, P.G., and Voytas, D.F.Zhu, Y., Dai, J., Fuerst, P.G., and Voytas, D.F. (2003) Controlling integration specificity of a yeast retrotransposon. Proc. Natl. Acad. Sci. U.S.A., 100, 5891-5895.
116. Kessl, J.J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S.F., and Engelman, A. et al. Kessl, J.J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S.F., and Engelman, A. (2012) A multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors. J. Biol. Chem., 287, 16801-16811.
117. Christ, F., Shaw, S., Demeulemeester, J., Desimmie, B.A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., and Debyser, Z. et al. Christ, F., Shaw, S., Demeulemeester, J., Desimmie, B.A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., and Debyser, Z. (2012) Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization. Antimicrob. Agents Chemother., 56, 4365-4374.
118. Tsiang, M., Jones, G.S., Niedziela-Majka, A., Kan, E., Lansdon, E.B., Huang, W., Hung, M., Samuel, D., Novikov, N., and Xu, Y. et al. Tsiang, M., Jones, G.S., Niedziela-Majka, A., Kan, E., Lansdon, E.B., Huang, W., Hung, M., Samuel, D., Novikov, N., and Xu, Y. (2012) New class of HIV-1 integrase (IN) inhibitors with a dual mode of action. J. Biol. Chem., 287, 21189-21203.
119. Pradeepa, M.M., Sutherland, H.G., Ule, J., Grimes, G.R., and Bickmore, W.A.Pradeepa, M.M., Sutherland, H.G., Ule, J., Grimes, G.R., and Bickmore, W.A. (2012) Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet., 8, e1002717.
120. Eidahl, J.O., Crowe, B.L., North, J.A., McKee, C.J., Shkriabai, N., Feng, L., Plumb, M., Graham, R.L., Gorelick, R.J., and Hess, S. et al. Eidahl, J.O., Crowe, B.L., North, J.A., McKee, C.J., Shkriabai, N., Feng, L., Plumb, M., Graham, R.L., Gorelick, R.J., and Hess, S. (2013) Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes. Nucleic Acids Res., 41, 3924-3936.
121. van Nuland, R., van Schaik, F.M., Simonis, M., van Heesch, S., Cuppen, E., Boelens, R., Timmers, H.M., and van Ingen, H.van Nuland, R., van Schaik, F.M., Simonis, M., van Heesch, S., Cuppen, E., Boelens, R., Timmers, H.M., and van Ingen, H. (2013) Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain. Epigenetics Chromatin, 6, 12.
122. Roth, S.L., Malani, N., and Bushman, F.D.Roth, S.L., Malani, N., and Bushman, F.D. (2011) Gammaretroviral integration into nucleosomal target DNA in vivo. J. Virol., 85, 7393-7401.
123. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., and Ozato, K.Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., and Ozato, K. (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. U.S.A., 100, 8758-8763.
124. Vollmuth, F., Blankenfeldt, W., and Geyer, M.Vollmuth, F., Blankenfeldt, W., and Geyer, M. (2009) Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. J. Biol. Chem., 284, 36547-36556.
125. Umehara, T., Nakamura, Y., Jang, M.K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B., and Yokoyama, S.Umehara, T., Nakamura, Y., Jang, M.K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B., and Yokoyama, S. (2010) Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem., 285, 7610-7618.
126. Zhang, W., Prakash, C., Sum, C., Gong, Y., Li, Y., Kwok, J.J.T., Thiessen, N., Pettersson, S., Jones, S.J.M., and Knapp, S. et al. Zhang, W., Prakash, C., Sum, C., Gong, Y., Li, Y., Kwok, J.J.T., Thiessen, N., Pettersson, S., Jones, S.J.M., and Knapp, S. (2012) Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J. Biol. Chem., 287, 43137-43155.
127. Gijsbers, R., Vets, S., De Rijck, J., Ocwieja, K.E., Ronen, K., Malani, N., Bushman, F.D., and Debyser, Z.Gijsbers, R., Vets, S., De Rijck, J., Ocwieja, K.E., Ronen, K., Malani, N., Bushman, F.D., and Debyser, Z. (2011) Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting. J. Biol. Chem., 286, 41812-41825.
128. Shun, M.C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J.E., Yan, N., Lieberman, J., Lavigne, M., and Engelman, A.Shun, M.C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J.E., Yan, N., Lieberman, J., Lavigne, M., and Engelman, A. (2008) Identification and characterization of PWWP domain residues critical for LEDGF/p75 chromatin binding and human immunodeficiency virus type 1 infectivity. J. Virol., 82, 11555-11567.
129. Wang, G.P., Ciuffi, A., Leipzig, J., Berry, C.C., and Bushman, F.D.Wang, G.P., Ciuffi, A., Leipzig, J., Berry, C.C., and Bushman, F.D. (2007) HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res., 17, 1186-1194.
130. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Muller, S., and Pawson, T. et al. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Muller, S., and Pawson, T. (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell, 149, 214-231.
131. Calo, E. and Wysocka, J.Calo, E. and Wysocka, J. (2013) Modification of enhancer chromatin: what, how, and why. Mol. Cell, 49, 825-837.
132. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Wang, L., Issner, R., and Coyne, M. et al. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Wang, L., Issner, R., and Coyne, M. (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473, 43-49.
133. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., Kastritis, E., Gilpatrick, T., Paranal, R.M., and Qi, J. et al. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., Kastritis, E., Gilpatrick, T., Paranal, R.M., and Qi, J. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell, 146, 904-917.
134. Lovén, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I., and Young, R.A.Lovén, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I., and Young, R.A. (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell, 153, 320-334.
135. Anders, L., Guenther, M.G., Qi, J., Fan, Z.P., Marineau, J.J., Rahl, P.B., Lovén, J., Sigova, A.A., Smith, W.B., and Lee, T.I. et al. Anders, L., Guenther, M.G., Qi, J., Fan, Z.P., Marineau, J.J., Rahl, P.B., Lovén, J., Sigova, A.A., Smith, W.B., and Lee, T.I. (2014) Genome-wide localization of small molecules. Nat. Biotechnol., 32, 92-96.
136. Nakajima, N., Lu, R., and Engelman, A.Nakajima, N., Lu, R., and Engelman, A. (2001) Human immunodeficiency virus type 1 replication in the absence of integrase-mediated DNA recombination: definition of permissive and nonpermissive T-cell lines. J. Virol., 75, 7944-7955.
137. Matreyek, K.A. and Engelman, A.Matreyek, K.A. and Engelman, A. (2013) Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes. Viruses, 5, 2483-2511.
138. Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O.Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J., 12, 2099-2108.
139. Yamashita, M. and Emerman, M.Yamashita, M. and Emerman, M. (2004) Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol., 78, 5670-5678.
140. Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J., Lieberman, J., and Elledge, S.J.Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J., Lieberman, J., and Elledge, S.J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science, 319, 921-926.
141. Konig, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M., Irelan, J.T., Chiang, C.Y., Tu, B.P., De Jesus, P.D., and Lilley, C.E. et al. Konig R. Zhou Y. Elleder D. Diamond T.L. Bonamy G.M. Irelan J.T. Chiang C.Y. Tu B.P. De Jesus P.D. and Lilley C.E. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell, 135, 49-60.
142. Zhou, H., Xu, M., Huang, Q., Gates, A.T., Zhang, X.D., Castle, J.C., Stec, E., Ferrer, M., Strulovici, B., and Hazuda, D.J. et al. Zhou, H., Xu, M., Huang, Q., Gates, A.T., Zhang, X.D., Castle, J.C., Stec, E., Ferrer, M., Strulovici, B., and Hazuda, D.J. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe, 4, 495-504.
143. Christ, F., Thys, W., De Rijck, J., Gijsbers, R., Albanese, A., Arosio, D., Emiliani, S., Rain, J.C., Benarous, R., and Cereseto, A. et al. Christ, F., Thys, W., De Rijck, J., Gijsbers, R., Albanese, A., Arosio, D., Emiliani, S., Rain, J.C., Benarous, R., and Cereseto, A. (2008) Transportin-SR2 imports HIV into the nucleus. Curr. Biol., 18, 1192-1202.
144. Ocwieja, K.E., Brady, T.L., Ronen, K., Huegel, A., Roth, S.L., Schaller, T., James, L.C., Towers, G.J., Young, J.A., and Chanda, S.K. et al. Ocwieja, K.E., Brady, T.L., Ronen, K., Huegel, A., Roth, S.L., Schaller, T., James, L.C., Towers, G.J., Young, J.A., and Chanda, S.K. (2011) HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog., 7, e1001313.
145. Matreyek, K.A., Yucel, S.S., Li, X., and Engelman, A.Matreyek, K.A., Yucel, S.S., Li, X., and Engelman, A. (2013) Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog., 9, e1003693.
146. Koh, Y., Wu, X., Ferris, A.L., Matreyek, K.A., Smith, S.J., Lee, K., KewalRamani, V.N., Hughes, S.H., and Engelman, A.Koh, Y., Wu, X., Ferris, A.L., Matreyek, K.A., Smith, S.J., Lee, K., KewalRamani, V.N., Hughes, S.H., and Engelman, A. (2013) Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration. J. Virol., 87, 648-658.
147. Di Nunzio, F., Fricke, T., Miccio, A., Valle-Casuso, J.C., Perez, P., Souque, P., Rizzi, E., Severgnini, M., Mavilio, F., and Charneau, P. et al. Di Nunzio, F., Fricke, T., Miccio, A., Valle-Casuso, J.C., Perez, P., Souque, P., Rizzi, E., Severgnini, M., Mavilio, F., and Charneau, P. (2013) Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology, 440, 8-18.
148. Meehan, A.M., Saenz, D.T., Guevera, R., Morrison, J.H., Peretz, M., Fadel, H.J., Hamada, M., van Deursen, J., and Poeschla, E.M.Meehan, A.M., Saenz, D.T., Guevera, R., Morrison, J.H., Peretz, M., Fadel, H.J., Hamada, M., van Deursen, J., and Poeschla, E.M. (2014) A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog., 10, e1003969.
149. Schaller, T., Ocwieja, K.E., Rasaiyaah, J., Price, A.J., Brady, T.L., Roth, S.L., Hue, S., Fletcher, A.J., Lee, K., and KewalRamani, V.N. et al. Schaller, T., Ocwieja, K.E., Rasaiyaah, J., Price, A.J., Brady, T.L., Roth, S.L., Hue, S., Fletcher, A.J., Lee, K., and KewalRamani, V.N. (2011) HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog., 7, e1002439.
150. Di Primio, C., Quercioli, V., Allouch, A., Gijsbers, R., Christ, F., Debyser, Z., Arosio, D., and Cereseto, A.Di Primio, C., Quercioli, V., Allouch, A., Gijsbers, R., Christ, F., Debyser, Z., Arosio, D., and Cereseto, A. (2013) Single-cell imaging of HIV-1 provirus (SCIP). Proc. Natl. Acad. Sci. U.S.A., 110, 5636-5641.
151. Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., and Bacharach, E.Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., and Bacharach, E. (2012) p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog., 8, e1003103.
152. Schneider, W.M., Brzezinski, J.D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F.D., and Roth, M.J.Schneider, W.M., Brzezinski, J.D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F.D., and Roth, M.J. (2013) Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. Proc. Natl. Acad. Sci. U.S.A., 110, 9487-9492.
153. Verma, I.M. and Weitzman, M.D.Verma, I.M. and Weitzman, M.D. (2005) Gene therapy: twenty-first century medicine. Annu. Rev. Biochem., 74, 711-738.
154. Boztug, K., Dewey, R.A., and Klein, C.Boztug, K., Dewey, R.A., and Klein, C. (2006) Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr. Opin. Mol. Ther., 8, 390-395.
155. Fischer, A., Hacein-Bey-Abina, S., and Cavazzana-Calvo, M.Fischer, A., Hacein-Bey-Abina, S., and Cavazzana-Calvo, M. (2011) Gene therapy for primary adaptive immune deficiencies. J. Allergy Clin. Immunol., 127, 1356-1359.
156. Rivat, C., Santilli, G., Gaspar, H.B., and Thrasher, A.J.Rivat, C., Santilli, G., Gaspar, H.B., and Thrasher, A.J. (2012) Gene therapy for primary immunodeficiencies. Hum. Gene Ther., 23, 668-675.
157. Biasco, L., Baricordi, C., and Aiuti, A.Biasco, L., Baricordi, C., and Aiuti, A. (2012) Retroviral integrations in gene therapy trials. Mol. Ther., 20, 709-716.
158. Wu, C. and Dunbar, C.E.Wu, C. and Dunbar, C.E. (2011) Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity. Front. Med., 5, 356-371.
159. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., and Kunkel, H. et al. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., and Kunkel, H. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med., 12, 401-409.
160. Boztug, K., Schmidt, M., Schwarzer, A., Banerjee, P.P., Diez, I.A., Dewey, R.A., Bohm, M., Nowrouzi, A., Ball, C.R., and Glimm, H. et al. Boztug, K., Schmidt, M., Schwarzer, A., Banerjee, P.P., Diez, I.A., Dewey, R.A., Bohm, M., Nowrouzi, A., Ball, C.R., and Glimm, H. (2010) Stem-cell gene therapy for the Wiskott-Aldrich syndrome.N. Engl. J. Med., 363, 1918-1927.
161. Stein, S., Ott, M.G., Schultze-Strasser, S., Jauch, A., Burwinkel, B., Kinner, A., Schmidt, M., Kramer, A., Schwable, J., and Glimm, H. et al. Stein, S., Ott, M.G., Schultze-Strasser, S., Jauch, A., Burwinkel, B., Kinner, A., Schmidt, M., Kramer, A., Schwable, J., and Glimm, H. (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med., 16, 198-204.
162. Lim, K.I.Lim, K.I. (2012) Retroviral integration profiles: their determinants and implications for gene therapy. BMB Rep., 45, 207-212.
163. Nienhuis, A.W., Dunbar, C.E., and Sorrentino, B.P.Nienhuis, A.W., Dunbar, C.E., and Sorrentino, B.P. (2006) Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther., 13, 1031-1049.
164. Trobridge, G.D.Trobridge, G.D. (2011) Genotoxicity of retroviral hematopoietic stem cell gene therapy. Expert. Opin. Biol. Ther., 11, 581-593.
165. Nowrouzi, A., Glimm, H., von Kalle, C., and Schmidt, M.Nowrouzi, A., Glimm, H., von Kalle, C., and Schmidt, M. (2011) Retroviral vectors: post entry events and genomic alterations. Viruses, 3, 429-455.
166. Knudson, A.G.Knudson, A.G. (2002) Cancer genetics. Am. J. Med. Genet., 111, 96-102.
167. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., and Stebbings, L.A. et al. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., and Stebbings, L.A. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27-40.
168. Yu, S.F., von Ruden, T., Kantoff, P.W., Garber, C., Seiberg, M., Ruther, U., Anderson, W.F., Wagner, E.F., and Gilboa, E.Yu, S.F., von Ruden, T., Kantoff, P.W., Garber, C., Seiberg, M., Ruther, U., Anderson, W.F., Wagner, E.F., and Gilboa, E. (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. U.S.A., 83, 3194-3198.
169. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C.C., Ranzani, M., Benedicenti, F., Sergi, L.S., Ambrosi, A., and Ponzoni, M. et al. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C.C., Ranzani, M., Benedicenti, F., Sergi, L.S., Ambrosi, A., and Ponzoni, M. (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest., 119, 964-975.
170. Cavazza, A., Cocchiarella, F., Bartholomae, C., Schmidt, M., Pincelli, C., Larcher, F., and Mavilio, F.Cavazza, A., Cocchiarella, F., Bartholomae, C., Schmidt, M., Pincelli, C., Larcher, F., and Mavilio, F. (2013) Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes. Gene Ther., 20, 949-957.
171. Mukherjee, S. and Thrasher, A.J.Mukherjee, S. and Thrasher, A.J. (2013) Gene therapy for PIDs: progress, pitfalls and prospects.Gene, 525, 174-181.
172. Zhao, Y., Yang, C.Y., andWang, S.Zhao, Y., Yang, C.Y., andWang, S. (2013) The making of I-BET762, a BET bromodomain inhibitor now in clinical development. J. Med. Chem., 56, 7498-7500.
173. (2014) Epigenetic therapy beneficial in blood cancers. Cancer Discovery, 4, OF7.
174. Donzella, G.A., Jonsson, C.B., and Roth, M.J.Donzella, G.A., Jonsson, C.B., and Roth, M.J. (1996) Coordinated disintegration reactions mediated by Moloney murine leukemia virus integrase. J. Virol., 70, 3909-3921.
175. Jonsson, C.B., Donzella, G.A., Gaucan, E., Smith, C.M., and Roth, M.J.Jonsson, C.B., Donzella, G.A., Gaucan, E., Smith, C.M., and Roth, M.J. (1996) Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J. Virol., 70, 4585-4597.
176. Schneider, W.M., Wu, D.T., Amin, V., Aiyer, S., and Roth, M.J.Schneider, W.M., Wu, D.T., Amin, V., Aiyer, S., and Roth, M.J. (2012) MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA. Virology, 426, 188-196.
177. Seamon, J.A., Adams, M., Sengupta, S., and Roth, M.J.Seamon, J.A., Adams, M., Sengupta, S., and Roth, M.J. (2000) Differential effects of C-terminal molecular tagged integrase on replication competent moloney murine leukemia virus. Virology, 274, 412-419.
178. Seamon, J.A., Jones, K.S., Miller, C., and Roth, M.J.Seamon, J.A., Jones, K.S., Miller, C., and Roth, M.J. (2002) Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection. J. Virol., 76, 8475-8484.
179. Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J.N., John, S., Jonsson, C.B., and Roth, M.J.Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J.N., John, S., Jonsson, C.B., and Roth, M.J. (2006) Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins. J. Virol., 80, 9497-9510.
180. Sakuma, T., Barry, M.A., and Ikeda, Y.Sakuma, T., Barry, M.A., and Ikeda, Y. (2012) Lentiviral vectors: basic to translational. Biochem J., 443, 603-618.
181. Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., and Westerman, K. et al. Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., and Westerman, K. (2010) Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature, 467, 318-322.
182. Wang, H., Shun, M.C., Li, X., Di Nunzio, F., Hare, S., Cherepanov, P., and Engelman, A.Wang, H., Shun, M.C., Li, X., Di Nunzio, F., Hare, S., Cherepanov, P., and Engelman, A. (2014) Efficient transduction of LEDGF/p75 mutant cells by complementary gain-of-function HIV-1 integrase mutant viruses. Mol.Ther. Methods Clin. Dev., 1, 2.
183. Floyd, S.R., Pacold, M.E., Huang, Q., Clarke, S.M., Lam, F.C., Cannell, I.G., Bryson, B.D., Rameseder, J., Lee, M.J., and Blake, E.J. et al. Floyd, S.R., Pacold, M.E., Huang, Q., Clarke, S.M., Lam, F.C., Cannell, I.G., Bryson, B.D., Rameseder, J., Lee, M.J., and Blake, E.J. (2013) The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature, 498, 246-250.
184. Jenkins, T.M., Esposito, D., Engelman, A., and Craigie, R.Jenkins, T.M., Esposito, D., Engelman, A., and Craigie, R. (1997) Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J., 16, 6849-6859.
185. Schwartz, R.M. and Dayhoff, M.O. Dayhoff, MOEd.Schwartz, R.M. and Dayhoff, M.O.In:edpp. Schwartz, R.M. and Dayhoff, M.O. (1978) In:Atlas of Protein Sequence and Structure, Dayhoff, MOEd. National Biochemical Research Foundation, Washington DC. pp. 353-358.
186. Metais, J., Topp, S., Doty, R., Borate, B., Nguyen, A., Wolfsberg, T., Abkowitz, J., and Dunbar, C.Metais, J., Topp, S., Doty, R., Borate, B., Nguyen, A., Wolfsberg, T., Abkowitz, J., and Dunbar, C. (2010) Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors. Gene Ther., 17, 799-804.